Synaffix appoints Dr Konstantinos Efthymiopoulos to its Board of Directors as Independent Chairman
– NETHERLANDS, Amsterdam – Synaffix BV, a biotechnology company exclusively focused on the development of industry-leading antibody-drug conjugate (ADC) technology, today announced the appointment of a panel of industry experts to its inaugural scientific advisory board (SAB).…